Extracranial multiorgan metastasis from primary glioblastoma: A case report

Table 1 Review the literature on extracranial metastases of malignant gliomas in the past five years

No.	Ag/sex	Location primary	Location metastasis	Diagnose	Interval	Survival	Adjuvant therapy
1	65/M	R occipital lobe	Bones (femur, ilium, sacrum)	GBM	13	11	Concurrent radiochemotherapy
2	20/W	L temporal lobe	Lung, lymph gland	GBM	NS	NS	Chemotherapy (temozolomide)
3	75/W	L temporal lobe	Lung, pleura	Diffuse astrocytoma	NS	NS	NS
4	48/W	L temporal lobe	Bone, lung, pleura, liver, mesentery	GBM	13	11	Concurrent radiochemotherapy
5	43/W	L frontal lobe	Lung, pleura	GBM	38	2	Concurrent radiochemotherapy
6	49/M	R temporal lobe	Lung, cerebrospinal fluid	GBM	12	10	Concurrent radiochemotherapy
7	56/W	R temporal lobe	Parotid, lymph node, lung	GBM	14.5	11	Concurrent radiochemotherapy
8	32/M	L basal ganglia region	Lymph nodes, bones (ribs, scapula, spine)	GBM	22	3	Concurrent radiochemotherapy
9	41/W	R temporal lobe	Lymphatic, spinal column	GBM	10	1	Concurrent radiochemotherapy
10	43/M	R temporal lobe	Multiple bone metastases	GBM	3	2	Radiotherapy
11	38/W	R temporal lobe	Lymph gland, bones	GBM	10	6	Concurrent radiochemotherapy
12	23/W	L temporal lobe	Lung, multiple bone metastases	Oligoastrocytoma	36	5	Concurrent radiochemotherapy
13	47/M	R temporal lobe	Scalp, lymph gland ribs, spine, liver, lungs	GBM	13	6	Concurrent radiochemotherapy

Interval: Time from diagnosis of primary to diagnosis of metastasis in months; Survival: Survival after diagnosis of metastasis in months. R: Right; L: Left; M: Male; F: Female; NS: Not stated or not known; GBM: Glioblastoma multiforme.